Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Nov 9, 2011, after the close
10-Q filed Nov 9, 2011, 40 days after period end · 0001144204-11-062616
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $103.42K | — |
| Net Income | -$3.21M | -$3.93M |
| EPS Diluted | -$0.07 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 9, 2011 · 40 d after period end
